Nav: Home

Patients with cancer seen in the emergency department have better outcomes at original hospital

April 23, 2019

Visual abstract link:http://www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180962/-/DC2

Patients with cancer requiring emergency department care had better outcomes at their original hospital or a cancer centre hospital than at alternative general hospitals, found research published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.180962

"Patients who were seen in an emergency department that was not associated with where they received cancer treatment or one of the 14 major cancer centres in the province were less likely to be admitted to hospital but more likely to die within 30 days of the visit," says Dr. Keerat Grewal, an emergency physician at Mount Sinai Hospital and the University of Toronto, Toronto, Ontario. "This may be because of a combination of factors, including a lack of cancer expertise at hospitals that do not routinely provide cancer care."

The study included data from ICES on 42 820 patients who were seen at an emergency department within 30 days of chemotherapy or radiation treatment between 2006 and 2011. Almost half of all patients who visited an emergency department for a cancer-related issue were admitted to hospital and, of these, about one-third visited hospitals other than the hospital where they were receiving cancer treatment.

Patients who visited hospitals that were not where they received their treatment and were not a cancer centre had a lower rate of admission and a higher likelihood of death within 30 days.

The authors suggest the lower admission rates may be because of lack of cancer expertise and missed markers of worsening disease.

"Emergency departments not affiliated with a cancer centre may not have the expertise to treat patients with cancer who often have complex medical histories," says Dr. Grewal. "Emergency department physicians who infrequently encounter patients with cancer cannot be expected to know the intricacies of cancer care with little or no exposure to how to treat these patients."
-end-
"The association of continuity of care and cancer centre affiliation with outcomes among patients with cancer who require emergency department care" is published April 23, 2019.

Joule Inc.

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...